Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 96

1.

Celecoxib in breast cancer prevention and therapy.

Li J, Hao Q, Cao W, Vadgama JV, Wu Y.

Cancer Manag Res. 2018 Oct 26;10:4653-4667. doi: 10.2147/CMAR.S178567. eCollection 2018. Review.

2.

Estrogen receptor-beta is a potential target for triple negative breast cancer treatment.

Austin D, Hamilton N, Elshimali Y, Pietras R, Wu Y, Vadgama J.

Oncotarget. 2018 Sep 21;9(74):33912-33930. doi: 10.18632/oncotarget.26089. eCollection 2018 Sep 21.

3.

Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells.

Chung SS, Dutta P, Austin D, Wang P, Awad A, Vadgama JV.

Oncotarget. 2018 Aug 31;9(68):32943-32957. doi: 10.18632/oncotarget.25993. eCollection 2018 Aug 31.

4.

Optimization Of Cancer Treatment Through Overcoming Drug Resistance.

Elshimali YI, Wu Y, Khaddour H, Wu Y, Gradinaru D, Sukhija H, Chung SS, Vadgama JV.

J Cancer Res Oncobiol. 2018;1(2). pii: 107. doi: 10.31021/jcro.20181107. Epub 2018 Feb 27.

5.

Targeting of PP2Cδ By a Small Molecule C23 Inhibits High Glucose-Induced Breast Cancer Progression In Vivo.

Wu K, Yu X, Huang Z, Zhu D, Yi X, Wu YL, Hao Q, Kemp KT 2nd, Elshimali Y, Iyer R, Nguyen KT, Zheng S, Chen G, Chen QH, Wang G, Vadgama JV, Wu Y.

Antioxid Redox Signal. 2018 Jul 13. doi: 10.1089/ars.2017.7486. [Epub ahead of print]

PMID:
29808718
6.

MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis.

Dutta P, Sarkissyan M, Paico K, Wu Y, Vadgama JV.

Breast Cancer Res Treat. 2018 Aug;170(3):477-486. doi: 10.1007/s10549-018-4760-8. Epub 2018 Mar 28.

7.

Time to Clinical Follow-up after Abnormal Mammogram among African American and Hispanic Women.

Petersen SS, Sarkissyan M, Wu Y, Clayton S, Vadgama JV.

J Health Care Poor Underserved. 2018;29(1):448-462. doi: 10.1353/hpu.2018.0030.

PMID:
29503311
8.

Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer.

Hamilton N, Austin D, Márquez-Garbán D, Sanchez R, Chau B, Foos K, Wu Y, Vadgama J, Pietras R.

Int J Mol Sci. 2017 Nov 2;18(11). pii: E2305. doi: 10.3390/ijms18112305.

9.

Association of Vitamin D3 Level with Breast Cancer Risk and Prognosis in African-American and Hispanic Women.

Wu Y, Sarkissyan M, Clayton S, Chlebowski R, Vadgama JV.

Cancers (Basel). 2017 Oct 24;9(10). pii: E144. doi: 10.3390/cancers9100144.

10.

Arctigenin inhibits prostate tumor cell growth in vitro and in vivo.

Wang P, Solorzano W, Diaz T, Magyar CE, Henning SM, Vadgama JV.

Clin Nutr Exp. 2017 Jun;13:1-11. doi: 10.1016/j.yclnex.2017.04.001. Epub 2017 Apr 8.

11.

Proinflammatory Cytokines IL-6 and TNF-α Increased Telomerase Activity through NF-κB/STAT1/STAT3 Activation, and Withaferin A Inhibited the Signaling in Colorectal Cancer Cells.

Chung SS, Wu Y, Okobi Q, Adekoya D, Atefi M, Clarke O, Dutta P, Vadgama JV.

Mediators Inflamm. 2017;2017:5958429. doi: 10.1155/2017/5958429. Epub 2017 Jun 6.

12.

GROα overexpression drives cell migration and invasion in triple negative breast cancer cells.

Bhat K, Sarkissyan M, Wu Y, Vadgama JV.

Oncol Rep. 2017 Jul;38(1):21-30. doi: 10.3892/or.2017.5668. Epub 2017 May 24.

13.

Androgen Receptor as a Potential Target for Treatment of Breast Cancer.

Wu Y, Vadgama JV.

Int J Cancer Res Mol Mech. 2017 Apr;3(1). doi: 10.16966/2381-3318.129. Epub 2016 Oct 6.

14.

A83-01 inhibits TGF-β-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells.

Wu Y, Tran T, Dwabe S, Sarkissyan M, Kim J, Nava M, Clayton S, Pietras R, Farias-Eisner R, Vadgama JV.

Breast Cancer Res Treat. 2017 Jun;163(3):449-460. doi: 10.1007/s10549-017-4211-y. Epub 2017 Mar 23.

15.

Salinomycin Abolished STAT3 and STAT1 Interactions and Reduced Telomerase Activity in Colorectal Cancer Cells.

Chung SS, Adekoya D, Enenmoh I, Clarke O, Wang P, Sarkyssian M, Wu Y, Vadgama JV.

Anticancer Res. 2017 Feb;37(2):445-453.

16.

Aberrant Phosphorylation of SMAD4 Thr277-Mediated USP9x-SMAD4 Interaction by Free Fatty Acids Promotes Breast Cancer Metastasis.

Wu Y, Yu X, Yi X, Wu K, Dwabe S, Atefi M, Elshimali Y, Kemp KT 2nd, Bhat K, Haro J, Sarkissyan M, Vadgama JV.

Cancer Res. 2017 Mar 15;77(6):1383-1394. doi: 10.1158/0008-5472.CAN-16-2012. Epub 2017 Jan 23.

17.

Lactate, a Neglected Factor for Diabetes and Cancer Interaction.

Wu Y, Dong Y, Atefi M, Liu Y, Elshimali Y, Vadgama JV.

Mediators Inflamm. 2016;2016:6456018. doi: 10.1155/2016/6456018. Epub 2016 Dec 18. Review.

18.

Long-term exposure of MCF-7 breast cancer cells to ethanol stimulates oncogenic features.

Gelfand R, Vernet D, Bruhn KW, Sarkissyan S, Heber D, Vadgama JV, Gonzalez-Cadavid NF.

Int J Oncol. 2017 Jan;50(1):49-65. doi: 10.3892/ijo.2016.3800. Epub 2016 Dec 9.

19.

Combination treatment with flavonoid morin and telomerase inhibitor MST‑312 reduces cancer stem cell traits by targeting STAT3 and telomerase.

Chung SS, Oliva B, Dwabe S, Vadgama JV.

Int J Oncol. 2016 Aug;49(2):487-98. doi: 10.3892/ijo.2016.3546. Epub 2016 May 31.

20.

Green tea and quercetin sensitize PC-3 xenograft prostate tumors to docetaxel chemotherapy.

Wang P, Henning SM, Magyar CE, Elshimali Y, Heber D, Vadgama JV.

J Exp Clin Cancer Res. 2016 May 6;35:73. doi: 10.1186/s13046-016-0351-x.

Supplemental Content

Loading ...
Support Center